EASY BIO,Inc. Statistics
Total Valuation
EASY BIO,Inc. has a market cap or net worth of KRW 171.36 billion. The enterprise value is 294.35 billion.
Market Cap | 171.36B |
Enterprise Value | 294.35B |
Important Dates
The last earnings date was Thursday, May 15, 2025.
Earnings Date | May 15, 2025 |
Ex-Dividend Date | Dec 27, 2024 |
Share Statistics
EASY BIO,Inc. has 33.08 million shares outstanding. The number of shares has decreased by -0.83% in one year.
Current Share Class | 33.08M |
Shares Outstanding | 33.08M |
Shares Change (YoY) | -0.83% |
Shares Change (QoQ) | -2.27% |
Owned by Insiders (%) | 1.34% |
Owned by Institutions (%) | 0.32% |
Float | 16.05M |
Valuation Ratios
The trailing PE ratio is 8.50 and the forward PE ratio is 5.58.
PE Ratio | 8.50 |
Forward PE | 5.58 |
PS Ratio | 0.39 |
PB Ratio | 1.95 |
P/TBV Ratio | 9.70 |
P/FCF Ratio | 10.34 |
P/OCF Ratio | 8.92 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 6.74, with an EV/FCF ratio of 17.76.
EV / Earnings | 14.38 |
EV / Sales | 0.67 |
EV / EBITDA | 6.74 |
EV / EBIT | 8.36 |
EV / FCF | 17.76 |
Financial Position
The company has a current ratio of 1.32, with a Debt / Equity ratio of 1.77.
Current Ratio | 1.32 |
Quick Ratio | 0.60 |
Debt / Equity | 1.77 |
Debt / EBITDA | 3.56 |
Debt / FCF | 9.38 |
Interest Coverage | 3.44 |
Financial Efficiency
Return on equity (ROE) is 26.91% and return on invested capital (ROIC) is 9.99%.
Return on Equity (ROE) | 26.91% |
Return on Assets (ROA) | 7.75% |
Return on Invested Capital (ROIC) | 9.99% |
Return on Capital Employed (ROCE) | 19.11% |
Revenue Per Employee | 3.37B |
Profits Per Employee | 156.29M |
Employee Count | 131 |
Asset Turnover | 1.56 |
Inventory Turnover | 6.16 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +21.88% in the last 52 weeks. The beta is 0.93, so EASY BIO,Inc.'s price volatility has been similar to the market average.
Beta (5Y) | 0.93 |
52-Week Price Change | +21.88% |
50-Day Moving Average | 5,205.70 |
200-Day Moving Average | 4,431.13 |
Relative Strength Index (RSI) | 46.37 |
Average Volume (20 Days) | 230,458 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, EASY BIO,Inc. had revenue of KRW 441.86 billion and earned 20.47 billion in profits. Earnings per share was 609.77.
Revenue | 441.86B |
Gross Profit | 106.41B |
Operating Income | 35.20B |
Pretax Income | 28.11B |
Net Income | 20.47B |
EBITDA | 43.68B |
EBIT | 35.20B |
Earnings Per Share (EPS) | 609.77 |
Balance Sheet
The company has 37.55 billion in cash and 155.51 billion in debt, giving a net cash position of -117.96 billion or -3,565.75 per share.
Cash & Cash Equivalents | 37.55B |
Total Debt | 155.51B |
Net Cash | -117.96B |
Net Cash Per Share | -3,565.75 |
Equity (Book Value) | 88.06B |
Book Value Per Share | 2,513.36 |
Working Capital | 40.41B |
Cash Flow
In the last 12 months, operating cash flow was 19.21 billion and capital expenditures -2.64 billion, giving a free cash flow of 16.58 billion.
Operating Cash Flow | 19.21B |
Capital Expenditures | -2.64B |
Free Cash Flow | 16.58B |
FCF Per Share | 501.06 |
Margins
Gross margin is 24.08%, with operating and profit margins of 7.97% and 4.63%.
Gross Margin | 24.08% |
Operating Margin | 7.97% |
Pretax Margin | 6.36% |
Profit Margin | 4.63% |
EBITDA Margin | 9.89% |
EBIT Margin | 7.97% |
FCF Margin | 3.75% |
Dividends & Yields
This stock pays an annual dividend of 200.00, which amounts to a dividend yield of 3.86%.
Dividend Per Share | 200.00 |
Dividend Yield | 3.86% |
Dividend Growth (YoY) | 100.00% |
Years of Dividend Growth | 2 |
Payout Ratio | 16.67% |
Buyback Yield | 0.83% |
Shareholder Yield | 4.64% |
Earnings Yield | 11.95% |
FCF Yield | 9.67% |
Stock Splits
The last stock split was on December 21, 2020. It was a forward split with a ratio of 5.
Last Split Date | Dec 21, 2020 |
Split Type | Forward |
Split Ratio | 5 |
Scores
EASY BIO,Inc. has an Altman Z-Score of 2.58. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 2.58 |
Piotroski F-Score | n/a |